Replies to post #332495 on Avid Bioservices Inc (CDMO)

[biopharm]

Yes, even more interesting is HC Wainwright covers other PS Targeting biotechs giving an update on Sept 10, 2019...same day they covered Avid CDMO.

...being "Omeros" that went public that PS Regulates Tumor Immunity etc

Sounds like the IP assets will provide Avid CDMO that $100+ pps

15% on net sales ...and manufacturing ...maybe Avid BOD should have held onto that warehouse storage space (if they did, we would be close to break even : )